Andrew J Greenfield is VP, CHIEF COMMERCIAL OFFICER of ABIOMED INC. Currently has a direct ownership of 0 shares of ABMD, which is worth approximately $0. The most recent transaction as insider was on Dec 22, 2022, when has been sold 23,484 shares (Common Stock, $.01 par value) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Andrew J Greenfield Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 22 2022
SELL
Sale (or disposition) back to the issuer
-
23,484 Reduced 100.0%
0 Common Stock, $.01 par...
Dec 16 2022
BUY
Grant, award, or other acquisition
-
14 Added 0.09%
15,977 Common Stock, $.01 par...
Nov 05 2022
SELL
Payment of exercise price or tax liability
$578,936 $373.99 p/Share
1,548 Reduced 3.15%
47,607 Common Stock, $.01 par...
Sep 30 2022
BUY
Grant, award, or other acquisition
-
34 Added 0.07%
49,155 Common Stock, $.01 par...
May 29 2022
SELL
Payment of exercise price or tax liability
$351,569 $266.34 p/Share
1,320 Reduced 2.62%
49,121 Common Stock, $.01 par...
May 29 2022
BUY
Grant, award, or other acquisition
-
2,150 Added 4.09%
50,441 Common Stock, $.01 par...
May 26 2022
BUY
Grant, award, or other acquisition
-
5,348 Added 9.97%
48,291 Common Stock, $.01 par...
May 25 2022
SELL
Payment of exercise price or tax liability
$75,255 $249.19 p/Share
302 Reduced 0.7%
42,943 Common Stock, $.01 par...
Mar 31 2022
BUY
Grant, award, or other acquisition
-
25 Added 0.06%
43,245 Common Stock, $.01 par...
Nov 03 2021
SELL
Payment of exercise price or tax liability
$541,778 $349.76 p/Share
1,549 Reduced 3.46%
43,220 Common Stock, $.01 par...
Nov 03 2021
BUY
Grant, award, or other acquisition
-
6,975 Added 13.48%
44,769 Common Stock, $.01 par...
Sep 30 2021
BUY
Grant, award, or other acquisition
-
26 Added 0.07%
37,794 Common Stock, $.01 par...
May 29 2021
SELL
Payment of exercise price or tax liability
$104,156 $284.58 p/Share
366 Reduced 0.96%
37,768 Common Stock, $.01 par...
May 25 2021
BUY
Grant, award, or other acquisition
-
2,000 Added 4.98%
38,134 Common Stock, $.01 par...
May 16 2021
SELL
Payment of exercise price or tax liability
$221,831 $268.56 p/Share
826 Reduced 2.23%
36,134 Common Stock, $.01 par...
Mar 31 2021
BUY
Grant, award, or other acquisition
-
30 Added 0.08%
36,960 Common Stock, $.01 par...
Jan 28 2021
SELL
Open market or private sale
$1,830,000 $366.0 p/Share
5,000 Reduced 13.54%
31,930 Common Stock, $.01 par...
Jan 28 2021
BUY
Exercise of conversion of derivative security
$331,250 $66.25 p/Share
5,000 Added 11.92%
36,930 Common Stock, $.01 par...
Dec 29 2020
SELL
Open market or private sale
$1,605,000 $321.0 p/Share
5,000 Reduced 15.66%
26,930 Common Stock, $.01 par...
Dec 22 2020
SELL
Open market or private sale
$499,773 $297.13 p/Share
1,682 Reduced 5.0%
31,930 Common Stock, $.01 par...
Dec 21 2020
SELL
Open market or private sale
$1,619,811 $295.91 p/Share
5,474 Reduced 14.01%
33,612 Common Stock, $.01 par...
Sep 30 2020
BUY
Grant, award, or other acquisition
-
43 Added 0.11%
39,086 Common Stock, $.01 par...
AJG

Andrew J Greenfield

VP, CHIEF COMMERCIAL OFFICER
Danvers, MA

Track Institutional and Insider Activities on ABMD

Follow ABIOMED INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABMD shares.

Notify only if

Insider Trading

Get notified when an Abiomed Inc insider buys or sells ABMD shares.

Notify only if

News

Receive news related to ABIOMED INC

Track Activities on ABMD